How can Arista AH be considered within a broader hemostasis strategy?

• A. As a replacement for proper surgical technique.
• B. As an adjunct to mechanical methods (compression, ligation, clamps) and other hemostats; not a replacement for proper surgical technique.
• C. Only for non-surgical bleeding.
• D. Works without any other technique.

Answer: (B)

Arista AH is best thought of as a supplement to the surgeon’s toolkit, not a replacement for proper technique. In a broad hemostasis strategy, the first priority is mechanical control—direct compression, ligation, and clamps to stop bleeding from identifiable vessels. Arista AH then provides an adjunctive boost by acting as a scaffold on oozing surfaces and absorbing water to concentrate the patient’s own platelets and clotting factors, helping to solidify clot formation when there’s diffuse or difficult-to-control bleeding.

Because it relies on the body’s coagulation system and adequate vascular control, it won’t stop brisk arterial bleeding by itself and isn’t intended for non-surgical bleeding. It should be used after applying standard mechanical methods and in conjunction with other hemostats as needed, not as the sole method of achieving hemostasis.